Evidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Orig...
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (207 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01815nam-a2200397z--4500 | ||
|---|---|---|---|
| 001 | 993546192904498 | ||
| 005 | 20231214133510.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202111s2020 xx |||||o ||| 0|eng d | ||
| 035 | |a (CKB)5400000000043972 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/74376 | ||
| 035 | |a (EXLCZ)995400000000043972 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Zhang, Yonggang |4 edt | |
| 245 | 1 | 0 | |a Evidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer |
| 260 | |b Frontiers Media SA |c 2020 | ||
| 300 | |a 1 electronic resource (207 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact | ||
| 546 | |a English | ||
| 650 | 7 | |a Science: general issues |2 bicssc | |
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a Evidence-based | ||
| 653 | |a immunotherapy | ||
| 653 | |a cancer | ||
| 653 | |a adverse event | ||
| 653 | |a management | ||
| 776 | |z 2-88966-247-0 | ||
| 700 | 1 | |a Ma, Xuelei |4 edt | |
| 700 | 1 | |a Zhou, Shuang |4 edt | |
| 700 | 1 | |a Zhang, Yonggang |4 oth | |
| 700 | 1 | |a Ma, Xuelei |4 oth | |
| 700 | 1 | |a Zhou, Shuang |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:55:59 Europe/Vienna |f system |c marc21 |a 2022-04-04 09:22:53 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338120410004498&Force_direct=true |Z 5338120410004498 |b Available |8 5338120410004498 | ||